{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T21:19:09Z","timestamp":1771708749383,"version":"3.50.1"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T00:00:00Z","timestamp":1478044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007175","name":"Conseil National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007175","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0165876","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T13:44:49Z","timestamp":1478094289000},"page":"e0165876","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["EGF-Induced VEGF Exerts a PI3K-Dependent Positive Feedback on ERK and AKT through VEGFR2 in Hematological In Vitro Models"],"prefix":"10.1371","volume":"11","author":[{"given":"Lilian","family":"Saryeddine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9887-072X","authenticated-orcid":true,"given":"Kazem","family":"Zibara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nouhad","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassam","family":"Badran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil","family":"El-Zein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,11,2]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1152\/physiol.00045.2009","article-title":"Roles for Growth Factors in Cancer Progression","volume":"25","author":"E Witsch","year":"2010","journal-title":"Physiology"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1158\/1541-7786.MCR-06-0404","article-title":"The Role of VEGF and EGFR Inhibition: Implications for Combining Anti -VEGF and Anti-EGFR Agents","volume":"5","author":"J Tabernero","year":"2007","journal-title":"Mol Cancer Res"},{"issue":"7","key":"ref3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrm1962","article-title":"EGF\u2013ERBB signalling: towards the systems levels","volume":"7","author":"A Citri","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","article-title":"Epidermal growth factor receptor (EGFR) signaling in cancer","volume":"366","author":"N Normanno","year":"2006","journal-title":"Gene"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular Endothelial Growth Factor: Basic Science and Clinical progress","volume":"25","author":"N Ferrara","year":"2004","journal-title":"Endocr Rev"},{"issue":"12","key":"ref6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nrc3627","article-title":"VEGF targets the tumour cell","volume":"13","author":"HL Goel","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/onc.2009.441","article-title":"Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics","volume":"29","author":"GL Semenza","year":"2010","journal-title":"Oncogene"},{"issue":"32","key":"ref8","doi-asserted-by":"crossref","first-page":"13092","DOI":"10.1073\/pnas.0702387104","article-title":"Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer","volume":"104","author":"A Franovic","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pharmthera.2011.03.012","article-title":"Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis","volume":"131","author":"AK Larsen","year":"2011","journal-title":"Pharmacol Ther"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.critrevonc.2006.11.006","article-title":"Angiogenesis and antiangiogenic therapy in hematologic malignancies","volume":"62","author":"X Dong","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1172\/JCI8978","article-title":"Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration","volume":"106","author":"S Dias","year":"2000","journal-title":"J Clin Invest"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/annonc\/mdn666","article-title":"Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma","volume":"20","author":"J Ruan","year":"2009","journal-title":"Ann Oncol"},{"issue":"29","key":"ref13","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.2174\/092986706779026174","article-title":"Targeting the EGFR Pathway for Cancer Therapy","volume":"13","author":"JB Johnston","year":"2006","journal-title":"Curr Med Chem"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/hon.1002","article-title":"Epidermal growth factor receptor expression in acute myelogenous leukaemia is associated with clinical prognosis","volume":"30","author":"JZ Sun","year":"2012","journal-title":"Hematol Oncol"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1182\/blood-2003-05-1510","article-title":"An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti\u2013IL-6 antibody-induced apoptosis","volume":"103","author":"K Mahtouk","year":"2004","journal-title":"Blood"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cellsig.2005.03.027","article-title":"The neuropeptide pituitary adenylate cyclase activating protein is a physiological activator of human monocytes","volume":"18","author":"N El Zein","year":"2006","journal-title":"Cell Signal"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4174\/astr.2015.89.1.1","article-title":"Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis","volume":"89","author":"SH Lee","year":"2015","journal-title":"Ann Surg Treat Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.lungcan.2016.01.003","article-title":"Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer","volume":"93","author":"CS Tan","year":"2016","journal-title":"Lung Cancer"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3892\/or.2012.2097","article-title":"Combination therapy with VEGFR2 and EGFR siRNA enhances the antitumor effect of cisplatin in non-small cell lung cancer xenografts","volume":"29","author":"S Chen","year":"2013","journal-title":"Oncol Rep"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/1947601911423031","article-title":"Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: A crucial target for anti- and pro-angiogenic therapies","volume":"2","author":"M Shibuya","year":"2011","journal-title":"Genes Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1186\/1471-2407-12-524","article-title":"The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer","volume":"12","author":"A Atmaca","year":"2012","journal-title":"BMC Cancer"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jaad.2010.04.026","article-title":"Tyrosine kinases in inflammatory dermatologic disease","volume":"65","author":"RT Paniagua","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00395-010-0141-0","article-title":"Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1\/2- and STAT1\/STAT3-dependent pathways and is attenuated by interferon-\u03b3","volume":"106","author":"S Demyanets","year":"2011","journal-title":"Basic Res Cardiol"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1172\/JCI65385","article-title":"Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer","volume":"123","author":"S Chatterjee","year":"2013","journal-title":"J Clin Invest"},{"issue":"46","key":"ref25","doi-asserted-by":"crossref","first-page":"32631","DOI":"10.1074\/jbc.274.46.32631","article-title":"p42\/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha)","volume":"274","author":"DE Richard","year":"1999","journal-title":"J Biol Chem"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cardiores.2004.09.032","article-title":"Transcriptional regulation of the Vascular Endothelial Growth Factor gene\u2013a concert of activating factors","volume":"65","author":"G Pag\u00e8s","year":"2005","journal-title":"Cardiovasc Res"},{"issue":"7","key":"ref27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a006502","article-title":"Signal Transduction by Vascular Endothelial Growth Factor Receptors","volume":"2","author":"S Koch","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1074\/jbc.M006966200","article-title":"A Critical Role for Phosphoinositide 3-Kinase Upstream of Gab1 and SHP2 in the Activation of Ras and Mitogen-activated Protein Kinases by Epidermal Growth Factor","volume":"276","author":"A Yart","year":"2001","journal-title":"J Biol Chem"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/carcin\/bgp244","article-title":"Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3\/JNK\/AP-1 pathway","volume":"30","author":"MH Chien","year":"2009","journal-title":"Carcinogenesis"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000047804","article-title":"Reactive Oxygen Species as Intracellular Messengers During Cell Growth and Differentiation","volume":"11","author":"H Sauer","year":"2001","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2008.02.044","article-title":"Reactive Oxygen Species and Angiogenesis: NADPH Oxidase as Target for Cancer Therapy","volume":"266","author":"M Ushio-Fukai","year":"2008","journal-title":"Cancer Lett"},{"issue":"24","key":"ref32","doi-asserted-by":"crossref","first-page":"10797","DOI":"10.1021\/jm301085w","article-title":"Vascular endothelial growth factor (VEGF) receptors: drugs and new inhibitors","volume":"55","author":"F Musumeci","year":"2012","journal-title":"J Med Chem"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0165876","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T02:55:44Z","timestamp":1568516144000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0165876"}},"subtitle":[],"editor":[{"given":"Marie-Jos\u00e9e","family":"Boucher","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,11,2]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0165876","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,2]]}}}